SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marc-Antoine Allard, Mylène Sebagh, Aldrick Ruiz, Catherine Guettier, Bernard Paule, Eric Vibert, Antonio Sa Cunha, Daniel Cherqui, Didier Samuel, Henri Bismuth, Denis Castaing, René Adam, Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?, Journal of Hepatology, 2015, 63, 1, 83

    CrossRef

  2. 2
    Francis Y. Yao, Neil Mehta, Jennifer Flemming, Jennifer Dodge, Bilal Hameed, Oren Fix, Ryutaro Hirose, Nicholas Fidelman, Robert K. Kerlan, John P. Roberts, Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria, Hepatology, 2015, 61, 6
  3. 3
    Eleonora Terzi, W. Ray Kim, William Sanchez, Michael R. Charlton, Paul Schmeltzer, Gregory J. Gores, James C. Andrews, Thomas C. Smyrk, Julie K. Heimbach, Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation, Liver Transplantation, 2015, 21, 2
  4. 4
    Beom Kyung Kim, Kyung Ah Kim, Myeong-Jin Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim, Mi-Suk Park, Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization, Digestive and Liver Disease, 2015,

    CrossRef

  5. 5
    Jeong-Heon Choi, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Young Ko, Dong Il Gwon, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee, Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma, Korean Journal of Hepato-Biliary-Pancreatic Surgery, 2015, 19, 2, 59

    CrossRef

  6. 6
    H-K Jiao, Y Xu, J Li, W Wang, Z Mei, X-D Long, G-Q Chen, Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma, Cell Death and Disease, 2015, 6, 3, e1689

    CrossRef

  7. 7
    M. Rodríguez-Fraile, M. Iñarrairaegui, Radioembolización de tumores hepáticos con 90Y-microesferas, Revista Española de Medicina Nuclear e Imagen Molecular, 2015, 34, 4, 244

    CrossRef

  8. 8
    M. Rodríguez-Fraile, M. Iñarrairaegui, Radioembolization with 90Y-microspheres for liver tumors, Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2015, 34, 4, 244

    CrossRef

  9. 9
    Terence P.F. Gade, Stephen J. Hunt, Neil Harrison, Gregory J. Nadolski, Charles Weber, Stephen Pickup, Emma E. Furth, Mitchell D. Schnall, Michael C. Soulen, M. Celeste Simon, Segmental Transarterial Embolization in a Translational Rat Model of Hepatocellular Carcinoma, Journal of Vascular and Interventional Radiology, 2015,

    CrossRef

  10. 10
    Wolfgang Sieghart, Florian Hucke, Markus Peck-Radosavljevic, Transarterial chemoembolization: Modalities, indication, and patient selection, Journal of Hepatology, 2015, 62, 5, 1187

    CrossRef

  11. 11
    Nishita Kothary, Chris Takehana, Kerstin Mueller, Patrick Sullivan, Ali Tahvildari, Jarrett Rosenberg, John D. Louie, Daniel Y. Sze, Watershed Hepatocellular Carcinomas: The Risk of Incomplete Response following Transhepatic Arterial Chemoembolization, Journal of Vascular and Interventional Radiology, 2015,

    CrossRef

  12. 12
    Simona Leoni, Fabio Piscaglia, Ilaria Serio, Eleonora Terzi, Irene Pettinari, Luca Croci, Sara Marinelli, Francesca Benevento, Rita Golfieri, Luigi Bolondi, Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group, Digestive and Liver Disease, 2014, 46, 6, 549

    CrossRef

  13. 13
    Bruno Sangro, Chemoembolization and radioembolization, Best Practice & Research Clinical Gastroenterology, 2014, 28, 5, 909

    CrossRef

  14. 14
    Zhe Guo, Jian-Hong Zhong, Jing-Hang Jiang, Jun Zhang, Bang-De Xiang, Le-Qun Li, Comparison of Survival of Patients with BCLC Stage A Hepatocellular Carcinoma After Hepatic Resection or Transarterial Chemoembolization: A Propensity Score-Based Analysis, Annals of Surgical Oncology, 2014, 21, 9, 3069

    CrossRef

  15. 15
    Bruno C. Odisio, Francisco Galastri, Rony Avritscher, Breno B. Afonso, Vanderlei Segatelli, Guilherme E. G. Felga, Paolo R. O. Salvalaggio, Joe Ensor, Michael J. Wallace, Felipe Nasser, Hepatocellular Carcinomas within the Milan Criteria: Predictors of Histologic Necrosis after Drug-eluting Beads Transarterial Chemoembolization, CardioVascular and Interventional Radiology, 2014, 37, 4, 1018

    CrossRef

  16. 16
    O. Seror, Percutaneous hepatic ablation: What needs to be known in 2014, Diagnostic and Interventional Imaging, 2014, 95, 7-8, 665

    CrossRef

  17. 17
    Mohammad Alaa Abusedera, Usama Ahmed Arafa, Elsayed Mostafa Ali, Transcatheter administration of buffered Lidocaine for pain relief due to transarterial chemoembolization for HCC, The Egyptian Journal of Radiology and Nuclear Medicine, 2014, 45, 2, 403

    CrossRef

  18. 18
    Alejandro Forner, Marine Gilabert, Jordi Bruix, Jean-Luc Raoul, Treatment of intermediate-stage hepatocellular carcinoma, Nature Reviews Clinical Oncology, 2014, 11, 9, 525

    CrossRef

  19. 19
    Young Hwan Koh, Joon-Il Choi, Hyun Beom Kim, Min Ju Kim, Computed Tomographic-Guided Radiofrequency Ablation of Recurrent or Residual Hepatocellular Carcinomas around Retained Iodized Oil after Transarterial Chemoembolization, Korean Journal of Radiology, 2013, 14, 5, 733

    CrossRef

  20. 20
    Farag M. Farag, Ehab E. Abdel-Khalek, Salah A. El-Gamal, Hany R. Shabana, Talal A. Amer, Evaluation of transarterial chemoembolization in treating hepatocellular carcinoma, Egyptian Liver Journal, 2013, 3, 2, 41

    CrossRef

  21. 21
    Alessandra Tovoli, Lucia Napoli, Marianna Mastroroberto, Matteo Renzulli, Manuel Tufoni, Carmen Serena Ricci, Rita Golfieri, Giovanni Brandi, Extrahepatic Feeding of HCC Limits the Use of TACE? Evidences from Literature and Clinical Experience, Journal of Cancer Therapy, 2013, 04, 02, 413

    CrossRef

  22. 22
    Matteo Cescon, Alessandro Cucchetti, Matteo Ravaioli, Antonio Daniele Pinna, Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate, Journal of Hepatology, 2013, 58, 3, 609

    CrossRef

  23. 23
    Rita Golfieri, Matteo Renzulli, Cristina Mosconi, Ludovica Forlani, Emanuela Giampalma, Fabio Piscaglia, Franco Trevisani, Luigi Bolondi, Hepatocellular Carcinoma Responding to Superselective Transarterial Chemoembolization: An Issue of Nodule Dimension?, Journal of Vascular and Interventional Radiology, 2013, 24, 4, 509

    CrossRef

  24. 24
    J.- F. Dufour, I. Bargellini, N. De Maria, P. De Simone, I. Goulis, R. T. Marinho, Intermediate hepatocellular carcinoma: current treatments and future perspectives, Annals of Oncology, 2013, 24, suppl 2, ii24

    CrossRef

  25. 25
    Damien Bisseret, Maxime Ronot, Mohamed Abdel-Rehim, Annie Sibert, Mohamed Bouattour, Laurent Castera, Jacques Belghiti, Valérie Vilgrain, Intratumoral Gas in Hepatocellular Carcinoma following Transarterial Chemoembolization: Associated Factors and Clinical Impact, Journal of Vascular and Interventional Radiology, 2013, 24, 11, 1623

    CrossRef

  26. 26
    Jessica P. Hwang, Anna S.-F. Lok, Management of patients with hepatitis B who require immunosuppressive therapy, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 4, 209

    CrossRef

  27. 27
    Irene Bargellini, Elena Bozzi, Daniela Campani, Paola Carrai, Paolo De Simone, Luca Pollina, Roberto Cioni, Franco Filipponi, Carlo Bartolozzi, Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT–pathologic correlation in 178 liver explants, European Journal of Radiology, 2013, 82, 5, e212

    CrossRef

  28. 28
    Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma, Digestive and Liver Disease, 2013, 45, 9, 712

    CrossRef

  29. 29
    Jianyong Lei, Wentao Wang, Lunan Yan, Surgical Resection versus Open-Approach Radiofrequency Ablation for Small Hepatocellular Carcinomas within Milan Criteria after Successful Transcatheter Arterial Chemoembolization, Journal of Gastrointestinal Surgery, 2013, 17, 10, 1752

    CrossRef

  30. 30
    Ian M. Breunig, Fadia T. Shaya, Nader Hanna, Brian Seal, Viktor V. Chirikov, C. Daniel Mullins, Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival, Value in Health, 2013, 16, 5, 760

    CrossRef

  31. 31
    Huan Tong, Xiao Li, Chun Le Zhang, Jin Hang Gao, Shi Lei Wen, Zhi Yin Huang, Fu Qiang Wen, Ping Fu, Cheng Wei Tang, Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts, Journal of Digestive Diseases, 2013, 14, 1
  32. 32
    Joshua L. Weintraub, Riad Salem, Treatment of Hepatocellular Carcinoma Combining Sorafenib and Transarterial Locoregional Therapy: State of the Science, Journal of Vascular and Interventional Radiology, 2013, 24, 8, 1123

    CrossRef

  33. 33
    Fabio Piscaglia, Eleonora Terzi, Alessandro Cucchetti, Chiara Trimarchi, Alessandro Granito, Simona Leoni, Sara Marinelli, Patrizia Pini, Luigi Bolondi, Treatment of hepatocellular carcinoma in Child-Pugh B patients, Digestive and Liver Disease, 2013, 45, 10, 852

    CrossRef

  34. 34
    J. -L. Raoul, M. Gilabert, M. Giovannini, A. Sarran, Chimioembolisation et hépatocarcinome: pour quel type de patient ?, Oncologie, 2012, 14, 3, 174

    CrossRef

  35. 35
    Sharon W. Kwan, Nicholas Fidelman, Elizabeth Ma, Robert K. Kerlan, Francis Y. Yao, Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: A radiological-pathological correlation, Liver Transplantation, 2012, 18, 6
  36. 36
    David Goldberg, Benjamin French, Peter Abt, Sandy Feng, Andrew M. Cameron, Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma, Liver Transplantation, 2012, 18, 4
  37. 37
    Bruno Sangro, Mercedes Iñarrairaegui, Jose I. Bilbao, Radioembolization for hepatocellular carcinoma, Journal of Hepatology, 2012, 56, 2, 464

    CrossRef

  38. 38
    E. Terzi, R. Golfieri, F. Piscaglia, M. Galassi, A. Dazzi, S. Leoni, E. Giampalma, M. Renzulli, L. Bolondi, Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”, Journal of Hepatology, 2012, 57, 6, 1258

    CrossRef

  39. 39
    Rajesh P. Shah, Karen T. Brown, Constantinos T. Sofocleous, Arterially Directed Therapies for Hepatocellular Carcinoma, American Journal of Roentgenology, 2011, 197, 4, W590

    CrossRef

  40. 40
    Jordi Bruix, Maria Reig, Jordi Rimola, Alejandro Forner, Marta Burrel, Ramón Vilana, Carmen Ayuso, Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques, Hepatology, 2011, 54, 6
  41. 41
    Nishita Kothary, Mohamed H.K. Abdelmaksoud, Alessia Tognolini, Rebecca Fahrig, Jarrett Rosenberg, David M. Hovsepian, Arundhuti Ganguly, John D. Louie, William T. Kuo, Gloria L. Hwang, Alison Holzer, Daniel Y. Sze, Lawrence V. Hofmann, Imaging Guidance with C-arm CT: Prospective Evaluation of Its Impact on Patient Radiation Exposure during Transhepatic Arterial Chemoembolization, Journal of Vascular and Interventional Radiology, 2011, 22, 11, 1535

    CrossRef

  42. 42
    Alessandro Cucchetti, Matteo Cescon, Eleonora Bigonzi, Fabio Piscaglia, Rita Golfieri, Giorgio Ercolani, Maria Cristina Morelli, Matteo Ravaioli, Antonio Daniele Pinna, Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy, Liver Transplantation, 2011, 17, 11
  43. 43
    Mathieu Boulin, Anne Ciboulet, Boris Guiu, Emilie Maillard, Franck Bonnetain, Anne Minello, Alice Gagnaire, Côme Lepage, Denis Krause, Patrick Hillon, Laurent Bedenne, Jean-Pierre Cercueil, Bruno Chauffert, Jean Louis Jouve, Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma, Digestive and Liver Disease, 2011, 43, 11, 905

    CrossRef

  44. 44
    D. F. Mirza, Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria (Br J Surg 2011; 98: 1201–1208), British Journal of Surgery, 2011, 98, 9
  45. 45
    Gisèle N'Kontchou, Olivier Seror, Michel Beaugrand, Who could Benefit from Chemoembolisation?,